Biotechnology Healthcare

Biotechnology Healthcare

The threat of new epidemics have encouraged the development of biological vaccines that promise dramatic improvements in health globally and locally. Several susceptible to prevention or treatment of chronic diseases. But uncertainties, including immunization raise the question whether the system of health care products promising to make this viable.

Today's challenges.

Once regarded as a chronic disease, Kaposi's sarcoma, Helicobacter pylori gastric ulcers and cancer of the cervix, among others, are now regarded as infectious diseases - and the trend seems to be reclassified chronic diseases, but more infectious. The current vaccines are either prophylactic or therapeutic. And whether a vaccine can actually be called therapy - a subject of contention among many researchers of diseases such terms are increasingly used to distinguish between, say, a vaccine against influenza and treatment of cancer.